The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment
2007

The Role of the Ubiquitin Proteasome System in Atherosclerosis and Diabetes

publication Evidence: moderate

Author Information

Author(s): Marfella Raffaele, D' Amico Michele, Di Filippo Clara, Siniscalchi Mario, Sasso Ferdinando Carlo, Ferraraccio Franca, Rossi Francesco, Paolisso Giuseppe

Primary Institution: Second University of Naples, Italy

Hypothesis

The ubiquitin proteasome system (UPS) may play a significant role in the development of atherosclerosis in diabetic patients.

Conclusion

The study suggests that the UPS is involved in the progression of atherosclerosis in diabetes, and targeting this system may help in therapeutic interventions.

Supporting Evidence

  • Diabetic patients have not benefited from advances in managing cardiovascular risk factors.
  • Insulin-resistance and chronic hyperglycemia are linked to atherosclerosis progression.
  • Oxidative stress can stimulate the UPS in macrophages, influencing inflammation.
  • Proteasome inhibitors may have therapeutic potential in reducing atherosclerosis progression.

Takeaway

This study looks at how a system in our cells that breaks down proteins might be linked to heart problems in people with diabetes.

Methodology

The study reviews existing literature on the UPS and its role in atherosclerosis in diabetic patients.

Limitations

The study is based on a limited number of existing studies on the UPS in diabetic cardiovascular diseases.

Digital Object Identifier (DOI)

10.1186/1475-2840-6-35

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication